BioCentury | Aug 17, 2019
Emerging Company Profile

Impact casting a wide synthetic lethality net

...to build discovery and development capabilities," said Bao, who joined Impact in October 2018 from Beijing Shenogen Pharma Group Ltd....
...Clinical Oncology, Alexandria, Va. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Bayer AG (Xetra:BAYN), Leverkusen, Germany Beijing Shenogen Pharma Group Ltd....
BioCentury | Aug 6, 2019
Company News

Aug. 6 Company Quick Takes: Sales updates from Alnylam, Sage, Regeneron and GW; plus regulatory updates from MorphoSys and more

...in the NDA. Innovent, Shenogen partner to pair drugs Innovent Biologics Inc. (HKSE:1801) partnered with Shenogen Pharma...
...MOR208, xmab5574) Allergan plc Alnylam Pharmaceuticals Inc. GW Pharmaceuticals plc Innovent Biologics Inc. Intra-Cellular Therapies Inc. Molecular Partners AG MorphoSys AG Regeneron Pharmaceuticals Inc. Sanofi Shenogen Pharma...
BioCentury | Mar 25, 2019
Emerging Company Profile

China Oncology Focus: funding combinations

...Therapeutics Inc., SillaJen Inc., Eleison Pharmaceuticals LLC, Adastra Pharmaceuticals Inc., Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Beijing Shenogen Pharma Group Ltd....
BioCentury | Jul 13, 2018
Finance

Pause for politics

...which are generally viewed as high quality and worthy of public capital. Jun Bao of Shenogen Pharma...
...Inc. (NYSE:PFE), New York, N.Y. Ping An Healthcare and Technology Co. Ltd. (HKSE:1833), Shanghai, China Shenogen Pharma...
BioCentury | May 25, 2018
Finance

HKEX’s on-demand experts

...panelists were not authorized to speak with the media. Jun Bao, SVP and CBO of Shenogen Pharma...
...Medicines Agency (EMA), London, U.K. Hua Medicine Ltd., Shanghai, China Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Shenogen Pharma...
BioCentury | Mar 16, 2018
Finance

Hong Kong’s new chapter

...pipeline that’s not there?” said Jun Bao, SVP and chief business officer of cancer company Shenogen Pharma...
...cover revenues, so how do they price a risky pipeline that’s not there?” Jun Bao, Shenogen Pharma...
...Taiwan OBI Pharma Inc. (TPEx:4174), Taipei, Taiwan Senhwa Biosciences Inc. (TPEx:6492), New Taipei City, Taiwan Shenogen Pharma...
BioCentury | Jan 5, 2018
Company News

Angiochem grants Xinogen Chinese rights to ANG1005

...to three paclitaxel molecules for receptor-mediated transport into the brain. Xinogen is a subsidiary of Shenogen Pharma...
...with brain metastases. Angiochem Inc., Montreal, Quebec Shenogen Pharma Group Ltd., Beijing, China Business: Cancer Mary Romeo ANG1005 Angiochem Inc. Shenogen Pharma...
BioCentury | Jan 3, 2018
Company News

Angiochem, Xinogen in China deal

...is eligible for milestones and royalties. Details were not disclosed. Xinogen is a subsidiary of Shenogen Pharma...
...completed a Phase I trial in patients with advanced solid tumors with brain metastases. Mary Romeo ANG1005 Angiochem Inc. Shenogen Pharma...
BioCentury | Dec 14, 2017
Company News

BayHelix names new board

...NASDAQ:QGEN) and general partner at Serica Capital. Bao is SVP and chief business officer of Shenogen Pharma...
BioCentury | Dec 1, 2017
Company News

Shenogen, Lee's forge another cancer combo deal

...Lee's Pharmaceutical Holdings Ltd. (HKSE:0950) and Shenogen Pharma Group Ltd. (Beijing, China) partnered to jointly develop and...
...Kong, China Shenogen Pharma Group Ltd., Beijing, China Business: Cancer Elizabeth S. Eaton icaritin companion diagnostic Pexa-Vec Lee's Pharmaceutical Holdings Ltd. Shenogen Pharma...
Items per page:
1 - 10 of 17
BioCentury | Aug 17, 2019
Emerging Company Profile

Impact casting a wide synthetic lethality net

...to build discovery and development capabilities," said Bao, who joined Impact in October 2018 from Beijing Shenogen Pharma Group Ltd....
...Clinical Oncology, Alexandria, Va. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Bayer AG (Xetra:BAYN), Leverkusen, Germany Beijing Shenogen Pharma Group Ltd....
BioCentury | Aug 6, 2019
Company News

Aug. 6 Company Quick Takes: Sales updates from Alnylam, Sage, Regeneron and GW; plus regulatory updates from MorphoSys and more

...in the NDA. Innovent, Shenogen partner to pair drugs Innovent Biologics Inc. (HKSE:1801) partnered with Shenogen Pharma...
...MOR208, xmab5574) Allergan plc Alnylam Pharmaceuticals Inc. GW Pharmaceuticals plc Innovent Biologics Inc. Intra-Cellular Therapies Inc. Molecular Partners AG MorphoSys AG Regeneron Pharmaceuticals Inc. Sanofi Shenogen Pharma...
BioCentury | Mar 25, 2019
Emerging Company Profile

China Oncology Focus: funding combinations

...Therapeutics Inc., SillaJen Inc., Eleison Pharmaceuticals LLC, Adastra Pharmaceuticals Inc., Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Beijing Shenogen Pharma Group Ltd....
BioCentury | Jul 13, 2018
Finance

Pause for politics

...which are generally viewed as high quality and worthy of public capital. Jun Bao of Shenogen Pharma...
...Inc. (NYSE:PFE), New York, N.Y. Ping An Healthcare and Technology Co. Ltd. (HKSE:1833), Shanghai, China Shenogen Pharma...
BioCentury | May 25, 2018
Finance

HKEX’s on-demand experts

...panelists were not authorized to speak with the media. Jun Bao, SVP and CBO of Shenogen Pharma...
...Medicines Agency (EMA), London, U.K. Hua Medicine Ltd., Shanghai, China Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Shenogen Pharma...
BioCentury | Mar 16, 2018
Finance

Hong Kong’s new chapter

...pipeline that’s not there?” said Jun Bao, SVP and chief business officer of cancer company Shenogen Pharma...
...cover revenues, so how do they price a risky pipeline that’s not there?” Jun Bao, Shenogen Pharma...
...Taiwan OBI Pharma Inc. (TPEx:4174), Taipei, Taiwan Senhwa Biosciences Inc. (TPEx:6492), New Taipei City, Taiwan Shenogen Pharma...
BioCentury | Jan 5, 2018
Company News

Angiochem grants Xinogen Chinese rights to ANG1005

...to three paclitaxel molecules for receptor-mediated transport into the brain. Xinogen is a subsidiary of Shenogen Pharma...
...with brain metastases. Angiochem Inc., Montreal, Quebec Shenogen Pharma Group Ltd., Beijing, China Business: Cancer Mary Romeo ANG1005 Angiochem Inc. Shenogen Pharma...
BioCentury | Jan 3, 2018
Company News

Angiochem, Xinogen in China deal

...is eligible for milestones and royalties. Details were not disclosed. Xinogen is a subsidiary of Shenogen Pharma...
...completed a Phase I trial in patients with advanced solid tumors with brain metastases. Mary Romeo ANG1005 Angiochem Inc. Shenogen Pharma...
BioCentury | Dec 14, 2017
Company News

BayHelix names new board

...NASDAQ:QGEN) and general partner at Serica Capital. Bao is SVP and chief business officer of Shenogen Pharma...
BioCentury | Dec 1, 2017
Company News

Shenogen, Lee's forge another cancer combo deal

...Lee's Pharmaceutical Holdings Ltd. (HKSE:0950) and Shenogen Pharma Group Ltd. (Beijing, China) partnered to jointly develop and...
...Kong, China Shenogen Pharma Group Ltd., Beijing, China Business: Cancer Elizabeth S. Eaton icaritin companion diagnostic Pexa-Vec Lee's Pharmaceutical Holdings Ltd. Shenogen Pharma...
Items per page:
1 - 10 of 17